A phase I, double-blind, randomized, placebo-controlled study to investigate the safety tolerability and pharmacokinetic profile of S-3304, a matrix metalloproteinase inhibitor, when given in multiple doses with high doses for 4 weeks to healthy volunteers

• Book ID: 117659604
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 277 KB
• Volume: 38
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(02)80912-1